The major theme of this Program Project Grant is to investigate the cellular and molecular biology of lipoprotein and cholesterol metabolism and to correlate the structure and function of specific apolipoproteins (and key enzymes in lipoprotein metabolism) with the mechanisms (pathways) involved in controlling lipoprotein levels and the development of atherosclerosis. A focus is to understand the structure and function of apolipoproteins (apo-) E and B, which are the ligands responsible for regulating plasma lipoprotein-receptor interactions. To accomplish these objectives, four projects and four cores have been assembled. The research is multidisciplinary and relies on X-ray crystallography, transgenic animals, homologous recombination, cellular biology, ultrastructural biology, animal physiology, and clinical investigations. Project 1, Structural and Biochemical Analysis of Apolipoprotein E, continues analysis of the three-dimensional structure and physical biochemistry of apoE and apoE variants. Project 2, Apolipoprotein E in Cholesterol Transport and Metabolism, focuses on defining the pathway mediating chylomicron remnant metabolism and on determining how defective apo-E causes type III hyperlipoproteinemia (the genetic disorder associated with premature atherosclerosis). Project 3, Mechanistic Studies of Hypobetalipoproteinemia, explores the molecular mechanisms responsible for causing the formation of truncated apo-B and low LDL levels, using a range of approaches from homologous recombination in mice to clinical studies in affected patients. Project 4, FDB and the Receptor Binding Domain of Apo-B, is designed to elucidate the receptor binding domain of apoB100 and to determine how a single amino acid change results in LDL which is defective in receptor binding, and responsible for the genetic disorder familial Defective ApoB100. The cores: Core A, Tissue Culture: Core B, Lipoprotein and Protein Production; Core C, Molecular Biology; and Core D, Administration; provide common services for accomplishing the goals of each project.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
2P01HL041633-06
Application #
2220104
Study Section
Heart, Lung, and Blood Research Review Committee B (HLBB)
Project Start
1989-02-01
Project End
1999-01-31
Budget Start
1994-03-05
Budget End
1995-01-31
Support Year
6
Fiscal Year
1994
Total Cost
Indirect Cost
Name
J. David Gladstone Institutes
Department
Type
DUNS #
047120084
City
San Francisco
State
CA
Country
United States
Zip Code
94158
Svensson, Annika W; Casey, Patrick J; Young, Stephen G et al. (2006) Genetic and pharmacologic analyses of the role of Icmt in Ras membrane association and function. Methods Enzymol 407:144-59
Ruiz, Jose; Kouiavskaia, Diana; Migliorini, Molly et al. (2005) The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor. J Lipid Res 46:1721-31
Sauer, Ines; Dunay, Ildiko R; Weisgraber, Karl et al. (2005) An apolipoprotein E-derived peptide mediates uptake of sterically stabilized liposomes into brain capillary endothelial cells. Biochemistry 44:2021-9
Kasravi, F Behzad; Lee, Diana H; Weisgraber, Karl et al. (2005) Lipoprotein-bound endotoxin exerts an immunomodulatory effect on hepatocytes through the lipid A domain of LPS. J Endotoxin Res 11:19-24
Schneider, Matthias; Witztum, Joseph L; Young, Stephen G et al. (2005) High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins. J Lipid Res 46:769-78
Bergo, Martin O; Gavino, Bryant J; Hong, Christine et al. (2004) Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf. J Clin Invest 113:539-50
Bergo, Martin O; Lieu, Hsiao D; Gavino, Bryant J et al. (2004) On the physiological importance of endoproteolysis of CAAX proteins: heart-specific RCE1 knockout mice develop a lethal cardiomyopathy. J Biol Chem 279:4729-36
Raffai, Robert L; Weisgraber, Karl H (2003) Cholesterol: from heart attacks to Alzheimer's disease. J Lipid Res 44:1423-30
Raffai, Robert L; McPherson, Ruth; Weisgraber, Karl H et al. (2003) Antibody phenotyping test for the human apolipoprotein E2 isoform. Clin Chem 49:1524-6
Liao, Wei; Hui, To Y; Young, Stephen G et al. (2003) Blocking microsomal triglyceride transfer protein interferes with apoB secretion without causing retention or stress in the ER. J Lipid Res 44:978-85

Showing the most recent 10 out of 168 publications